Pharma-Bio Serv (PBSV) Receivables - Net (2010 - 2026)

Pharma-Bio Serv's Receivables - Net history runs 17 years deep, the most recent figure standing at $2.7 million for Q2 2026.

• Quarterly Receivables - Net fell 48.62% year-over-year to $2.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.7 million (down 48.62% YoY) and the FY2025 annual result came in at $5.3 million, changed 0.0% from the prior year.
• Receivables - Net was $2.7 million for Q2 2026 at Pharma-Bio Serv, up from $2.7 million in the prior quarter.
• Across five years, Receivables - Net topped out at $5.5 million in Q2 2022 and bottomed at $2.0 million in Q3 2025.
• A 5-year average of $4.1 million and a median of $4.7 million in 2022 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2022 — Receivables - Net soared 858.17% — and 2025, when it sank 61.97%.
• Pharma-Bio Serv's Receivables - Net stood at $5.0 million in 2022, then fell by 20.91% to $3.9 million in 2023, then tumbled by 36.29% to $2.5 million in 2024, then fell by 5.98% to $2.4 million in 2025, then advanced by 15.37% to $2.7 million in 2026.
• Business Quant data shows PBSV's Receivables - Net at $2.7 million in Q2 2026, $2.7 million in Q1 2026, and $2.4 million in Q4 2025.